This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Greatbatch Announces The Acquisition Of NeuroNexus

Greatbatch, Inc., (NYSE:GB) today announced the acquisition of NeuroNexus Technologies (“NeuroNexus”) for approximately $12 million in cash, including the assumption of debt and future considerations.

NeuroNexus, headquartered in Ann Arbor, Michigan, is an active implantable medical device design firm specializing in developing and commercializing high-value neural interface technology, components and systems for neuroscience and clinical markets. The company has an extensive intellectual property portfolio, core technologies and capabilities to support the development and manufacturing of innovative neural interface devices across a wide range of functions including neuromodulation, sensing, optical stimulation and targeted drug delivery applications.

“We are very excited to have the NeuroNexus team join the QiG Group and Greatbatch family of companies. Together, we believe that we can research, design, develop and manufacture new world-class proprietary products and systems that will expand and potentially re-define the fields of cardiovascular and neuromodulation as we know them today,” stated Thomas J. Hook, President and CEO of Greatbatch, Inc. “Additionally, the strong alliance NeuroNexus has with the University of Michigan and the Michigan Economic Development Corporation should position us to expand our operations in the region.”

Daryl R. Kipke PhD., NeuroNexus President and CEO, stated, “We are delighted to have this opportunity to strengthen and accelerate our position as a world-class leader in neural interface devices. Our innovative, high fidelity and high precision lead technologies combined with QiG Group and Greatbatch capabilities will ensure the achievement of our goals of advancing cardiovascular and neuromodulation clinical therapies and providing innovative research products to leading neuroscientists around the world to fuel progress in neuroscience. Additionally, we are excited that this opportunity allows us to continue and expand our presence in the high-technology hub of Ann Arbor and the broader Michigan region.”

NeuroNexus, founded in 2004, employs approximately 25 associates in its Ann Arbor facility. The highly talented team, many of whom possess advanced doctorate degrees in engineering and neuroscience, have diverse capabilities in medical device development. “The world class team further strengthens our QiG Group’s research, development and engineering talent and expands our footprint in key strategic locations,” Hook concluded.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,689.67 -28.87 -0.16%
S&P 500 2,057.04 -4.01 -0.19%
NASDAQ 4,863.61 -12.9090 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs